96 related articles for article (PubMed ID: 18277066)
1. Ultrasound patterns of parathyroid glands in chronic hemodialysis patients with secondary hyperparathyroidism.
Vulpio C; Bossola M; De Gaetano A; Maresca G; Di Stasio E; Spada PL; Romitelli F; Luciani G; Castagneto M
Am J Nephrol; 2008; 28(4):589-97. PubMed ID: 18277066
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid-gland ultrasonography in clinical and therapeutic evaluation of renal secondary hyperparathyroidism.
Vulpio C; Bossola M; Magalini SC; Silvestri P; Fadda G; Ciliberti M; D'Andrea ML; Maresca G
Radiol Med; 2013 Aug; 118(5):707-22. PubMed ID: 23090243
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid gland ultrasound patterns and biochemical findings after one-year cinacalcet treatment for advanced secondary hyperparathyroidism.
Vulpio C; Bossola M; De Gaetano A; Maresca G; Di Stasio E; Zagaria L; Luciani G; Giordano A; Castagneto M
Ther Apher Dial; 2010 Apr; 14(2):178-85. PubMed ID: 20438540
[TBL] [Abstract][Full Text] [Related]
4. Use of ultrasound to assess the response to therapy for secondary hyperparathyroidism.
Meola M; Petrucci I; Colombini E; Barsotti G
Am J Kidney Dis; 2011 Sep; 58(3):485-91. PubMed ID: 21715073
[TBL] [Abstract][Full Text] [Related]
5. Switch from calcitriol to paricalcitol in secondary hyperparathyroidism of hemodialysis patients: Responsiveness is related to parathyroid gland size.
Vulpio C; Maresca G; Distasio E; Cacaci S; Panocchia N; Luciani G; Bossola M
Hemodial Int; 2011 Jan; 15(1):69-78. PubMed ID: 21223484
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound in clinical setting of secondary hyperparathyroidism.
Meola M; Petrucci I; Cupisti A
J Nephrol; 2013; 26(5):848-55. PubMed ID: 23042437
[TBL] [Abstract][Full Text] [Related]
7. Risk-factors for nodular hyperplasia of parathyroid glands in sHPT patients.
Jäger MD; Serttas M; Beneke J; Müller JA; Schrem H; Kaltenborn A; Ramackers W; Ringe BP; Gwiasda J; Tränkenschuh W; Klempnauer J; Scheumann GFW
PLoS One; 2017; 12(10):e0186093. PubMed ID: 29040300
[TBL] [Abstract][Full Text] [Related]
8. The value of clinical-ultrasonographic feature model to predict the severity of secondary hyperparathyroidism.
Zhang X; Xu W; Huang T; Huang J; Zhang C; Zhang Y; Xie X; Xu M
Ren Fail; 2022 Dec; 44(1):146-154. PubMed ID: 35164637
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of parathyroid gland angiogenesis in chronic kidney disease associated with secondary hyperparathyroidism.
Martins P; Schmitt F; Almeida H; Frazão JM
Nephrol Dial Transplant; 2008 Sep; 23(9):2889-94. PubMed ID: 18398016
[TBL] [Abstract][Full Text] [Related]
10. Preoperative evaluation of hyperparathyroidism: the role of dual-phase parathyroid scintigraphy and ultrasound imaging.
Sukan A; Reyhan M; Aydin M; Yapar AF; Sert Y; Canpolat T; Aktas A
Ann Nucl Med; 2008 Feb; 22(2):123-31. PubMed ID: 18311537
[TBL] [Abstract][Full Text] [Related]
11. Presurgical setting of secondary hyperparathyroidism using high-resolution sonography and color Doppler.
Meola M; Petrucci I; Calliada F; Barsotti M; Puccini M; Grosso M; Barsotti G
Ultraschall Med; 2011 Jan; 32 Suppl 1():S74-82. PubMed ID: 20414855
[TBL] [Abstract][Full Text] [Related]
12. Ultrasound-based scores as predictors for nodular hyperplasia in patients with secondary hyperparathyroidism: a prospective validation study.
Gwiasda J; Kaltenborn A; Müller JA; Serttas M; Scheumann GW; Schrem H; Jäger MD
Langenbecks Arch Surg; 2017 Mar; 402(2):295-301. PubMed ID: 28054194
[TBL] [Abstract][Full Text] [Related]
13. The Significance of Ultrasound in Determining Whether SHPT Patients Are Sensitive to Calcitriol Treatment.
Liang XX; Li F; Gao F; Li CX; Qiao XH; Zhang JJ; Du LF
Biomed Res Int; 2016; 2016():6193751. PubMed ID: 27034943
[TBL] [Abstract][Full Text] [Related]
14. [Ultrasound parameter-based response to treatment with new drugs for secondary hyperparathyroidism: a retrospective analysis in a single dialysis center].
Vulpio C; Bossola M; De Gaetano A; Maresca G; Panocchia N; Spada P; Tazza L; Luciani G; Castagneto M
G Ital Nefrol; 2010; 27(5):527-35. PubMed ID: 20922685
[TBL] [Abstract][Full Text] [Related]
15. Sestamibi scintigraphy, topography, and histopathology of parathyroid glands in secondary hyperparathyroidism.
Lomonte C; Buonvino N; Selvaggiolo M; Dassira M; Grasso G; Vernaglione L; Basile C
Am J Kidney Dis; 2006 Oct; 48(4):638-44. PubMed ID: 16997060
[TBL] [Abstract][Full Text] [Related]
16. Maximal parathyroid gland diameter as a predictive factor for autograft-dependent recurrent secondary hyperparathyroidism after total parathyroidectomy.
Hiramitsu T; Hasegawa Y; Futamura K; Okada M; Goto N; Narumi S; Watarai Y; Tominaga Y; Ichimori T
Front Endocrinol (Lausanne); 2023; 14():1175237. PubMed ID: 37396185
[TBL] [Abstract][Full Text] [Related]
17. Parathyroid Ultrasonography in Renal Secondary Hyperparathyroidism: An Overlooked and Useful Procedure.
Vulpio C; Bossola M
Semin Dial; 2016 Sep; 29(5):347-9. PubMed ID: 27419923
[TBL] [Abstract][Full Text] [Related]
18. Histology and immunohistochemistry of the parathyroid glands in renal secondary hyperparathyroidism refractory to vitamin D or cinacalcet therapy.
Vulpio C; Bossola M; Di Stasio E; Tazza L; Silvestri P; Fadda G
Eur J Endocrinol; 2013 Jun; 168(6):811-9. PubMed ID: 23520248
[TBL] [Abstract][Full Text] [Related]
19. Clinical features and hyperplastic patterns of parathyroid glands in hemodialysis patients with advanced secondary hyperparathyroidism refractory to maxacalcitol treatment and required parathyroidectomy.
Tominaga Y; Matsuoka S; Sato T; Uno N; Goto N; Katayama A; Haba T;
Ther Apher Dial; 2007 Aug; 11(4):266-73. PubMed ID: 17661832
[TBL] [Abstract][Full Text] [Related]
20. Microwave ablation: an effective treatment for mild-to-moderate secondary hyperparathyroidism in patients undergoing haemodialysis.
Wang G; Liu S; Liu X; Qian L; Diao Z; Liu W
Int J Hyperthermia; 2017 Dec; 33(8):946-952. PubMed ID: 28768451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]